SWK’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

SWK is a finance company that provides capital to a range of life science companies, institutions and inventors. Read more

CEO Avatar

CEO

Winston Black

CEO Approval Rating

79/100

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Capital IP Investment Partners is SWK's #1 competitor. Capital IP Investment Partners was founded in San Francisco, California} in 2004. Capital IP Investment Partners operates in the Investment Management & Fund Operators industry. Compared to SWK, Capital IP Investment Partners generates $23.7M less revenue.

Royalty Pharma is one of SWK's top competitors. Royalty Pharma was founded in 1996 in New York, New York. Royalty Pharma operates in the Diversified Investment Services industry. Royalty Pharma generates $1.9B more revenue than SWK.

HealthCare Royalty Partners is a top competitor of SWK. HealthCare Royalty Partners was founded in 2007, and is headquartered in Stamford, Connecticut. HealthCare Royalty Partners is in the Mortgage Finance industry. HealthCare Royalty Partners generates $20.7M less revenue vs. SWK.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Athyrium a competitor of SWK?

Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$28.7M

SWK's revenue is the ranked 2nd among it's top 10 competitors. The top 10 competitors average 221.9M. Over the last three quarters, SWK's revenue has grown by 15%. Specifically, in Q1 2020's revenue was $7.3M; in Q4 2019, it was $7.5M; in Q3 2019, it was $6.3M.

Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION
Enteris BioPharma, Inc.

Aug 2019

Source »
$21.5M
Enteris BioPharma is a biopharmaceutical company that develops peptide-based oral therapeutics for the treatment of metabolic disorders.

These are all the companies that SWK has acquired. SWK's latest acquisition was Enteris BioPharma, Inc. in Aug 2019. Enteris BioPharma is a biopharmaceutical company that develops peptide-based oral therapeutics for the treatment of metabolic disorders.

SWK Funding History

$20M

Since SWK was founded in 1996, it has participated in 1 round of funding. In total SWK has raised $20.0M. SWK's funding round was on Jul 2018 for a total of $20.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Debt
Jul 2018
$20M

AloStar Capital Finance

Total Funding: $20M

Since SWK was founded in 1996, it has participated in 1 round of funding. In total SWK has raised $20.0M. SWK's funding round was on Jul 2018 for a total of $20.0M

Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

Eton Pharma is a pharmaceutical company that researches, develops and commercializes injectables, oral liquids and ophthalmics.
$10M
Nov 12, 2019
Debt
Nov 12, 2018
4WEB develops and manufactures 3D printed medical devices for the knee, hip, trauma and patient-specific orthopedic procedures.
-
Jun 12, 2019
Equity
-
Cheetah Medical manufactures and distributes noninvasive hemodynamic monitoring systems for volume management and perfusion optimization.
$20M
Feb 13, 2019
Debt
Sep 01, 2019
EyePoint is a bio-pharmaceutical company that engages in developing and commercializing ophthalmic products.
$60M
Feb 12, 2019
Debt
-
EyePoint is a bio-pharmaceutical company that engages in developing and commercializing ophthalmic products.
$20M
Mar 27, 2018
Debt
-

These are all the companies that SWK has invested in. SWK's latest investment was Enteris BioPharma, Inc. in Aug 2019. Enteris BioPharma is a biopharmaceutical company that develops peptide-based oral therapeutics for the treatment of metabolic disorders.

SWK News

September 2, 2020Zolmax News

Colliers Secur. Research Analysts Lift Earnings Estimates for SWK Holdings Corp (OTCMKTS:SWKH)

SWK Holdings Corp (OTCMKTS:SWKH) - Stock analysts at Colliers Secur. raised their FY2020 earnings per... See more »
August 31, 2020BioSpace

PDL BioPharma Announces Sale of Kybella, Zalviso and Coflex Royalties to SWK Holdings Corporation

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) announces the signing and closing of a de... See more »
August 21, 2020Zolmax News

SWK Holdings Corp Forecasted to Earn Q3 2020 Earnings of $0.33 Per Share (OTCMKTS:SWKH)

SWK Holdings Corp (OTCMKTS:SWKH) - Colliers Secur. issued their Q3 2020 earnings per share estimates ... See more »
August 17, 2020MarketScreener

Shareholder Presentation 2Q20

(marketscreener.com) Collaborative Approach to Life Science Financing Q2 2020 Shareholder Presentatio... See more »

SWK Press Releases

January 15, 2020centralcharts

SWK Holdings 'uncovering biotech gems' in the generic drug and medical device space

SWK Holdings CEO Winston Black spoke with Proactive's Christine Corrado at the Biotech Showcase 2020 ... See more »
September 16, 2019centralcharts

SWK Holdings to Present at the Fall Investor Summit

SWK Holdings to Present at the Fall Investor Summit Presentation Scheduled for Today, September 16, 2... See more »
August 10, 2017GlobalNewswire

Opiant Pharmaceuticals, Inc. Announces Additional $3.75 Million Payment From NARCAN® Nasal Spray Royalty Monetization

Company Received Additional Payment From SWK Funding LLC Based on Achievement of $25 Million Net Sale... See more »

Headquarters

14755 Preston Rd Suite 105

Dallas, Texas75254

972-687-7250

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

SWK is a finance company that provides capital to a range of life science companies, institutions and inventors. SWK was founded in 1996. SWK's headquarters is located in Dallas, Texas, USA 75254. It has raised 20.0M in 1 round. The latest round was i...

CEO

SWK's CEO, Winston Black, currently has an approval rating of 79%. SWK's primary competitors are Capital IP Investment Partners, Royalty Pharma & HealthCare Royalty Partners.

Website

swkhold.com

Frequently Asked Questions about SWK

  1. When was SWK founded?

    SWK was founded in 1996
  2. Who is SWK's CEO?

    SWK's CEO is Winston Black
  3. How much revenue does SWK generate?

    SWK generates $28.7M in revenue
  4. How much funding does SWK have?

    SWK has historically raised $20M in funding
  1. Where is SWK's headquarters?

    SWK's headquarters is in Dallas Texas, USA
  2. How many employees does SWK have?

    SWK has 30 employees
  3. Who are SWK's competitors?

    SWK's top competitors are Capital IP Investment Partners, Royalty Pharma, HealthCare Royalty Partners
  4. Who has SWK invested in?

    SWK's has invested in companies such as Eton Pharma, 4WEB, Cheetah Medical